Navigation Links
BellaDerm(TM), a Unique Human Skin Tissue Implant for Facial and Body Contouring, is Introduced by MTF
Date:6/10/2009

EDISON, N.J., June 10 /PRNewswire/ -- BellaDerm, the first human dermal tissue graft offered specifically for facial and body contouring procedures, is being introduced today by MTF, the Musculoskeletal Transplant Foundation, the country's leading non-profit tissue bank.

BellaDerm is a unique acellular matrix, derived from donated human allograft skin. The new tissue has properties that are very appealing to plastic surgeons. In addition to coming from human donors, it provides excellent handling characteristics and the added benefit of being in ready-to-use form. It is easily accessible and ready for surgeon selection at all times. Unlike some other dermal tissues, it does not require refrigeration.

BellaDerm provides supplemental support in areas of weakness. It has been used by plastic surgeons to address naturally occurring defects which may be found in areas such as the breast, lips, and face.

Michael Kawas, President of MTF's skin division, notes that plastic surgeons typically rely on other materials; some of them from animals (like pigs) and some of them are synthetic. "Now they will have an option to use human skin, which provides a more natural choice. We have gotten a lot of comments about the desirability of implanting 'like into like' - in other words, implanting tissue from one human into another. It seems to be preferable to using animal products or synthetic materials."

"We have a history of positive clinical outcomes using other MTF tissue," noted Dr. Philip Bonanno, Director of the Institute of Aesthetic Surgery and Medicine at Northern Westchester Hospital in Mt. Kisco, New York. "Thus we're comfortable using BellaDerm as a natural human dermal graft for support and reinforcement in many of our procedures."

Donation of skin for BellaDerm is restricted to living donors who have given specific consent for their skin to be used for these types of procedures. To assure the utmost safety and quality, MTF has the highest standards for tissue donation. Living skin donations are held to the same high standards for acceptance and processing as skin which is recovered from deceased donors.

"It is very important for us to have confidence in the providers of all materials we use," continues Dr. Bonanno, "and MTF's high standards exemplify their commitment to providing only the best tissue possible for my patients."

MTF is a non-profit service organization that has been dedicated to providing high quality tissue to health care providers for over 20 years. Since its founding by surgeons in 1987, MTF has received tissue from more than 74,000 donors and has provided more than 3.5 million tissue grafts for transplantation. For more information, visit www.mtf.org. For more information about BellaDerm, visit www.BellaDerm.org.

    Media contact:
    Cindy Gordon
    609-252-1300

'/>"/>
SOURCE MTF
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Beazleys New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations
2. Here to Help(TM): Unique Program Combines Direct Personal Assistance With Web-Based Resources to Improve Opioid Dependence Treatment Outcomes
3. Henry Ford Hospital: Unique Patient Study -- No Informed Consent
4. 200 Families of Children With Serious Eye Problems Benefit From Unique Gift Card Program at The Vision Center at Childrens Hospital Los Angeles
5. Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis
6. Four Unique Gifts for Expectant Moms Includes New Technology That Enhances Pre-Natal Bonding
7. Researchers design unique method to induce immunity to certain STDs
8. SOURCECORP(R) HealthSERVE Unveils Unique Tool for Healthcare Providers to Support Recovery Audit Contractor (RAC) Program Defense
9. National Radio Program to Expand Awareness of TrinityCares Unique Approach to Senior Adult Care
10. Video: Adults Facing ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page
11. Pittsburgh Hospital Teams with Pirates Baseball Club in Unique Effort to Encourage Teen Handwashing, Prevent Spread of MRSA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: